Skip to main content
. Author manuscript; available in PMC: 2013 Dec 6.
Published in final edited form as: J Am Geriatr Soc. 2012 May;60(5):10.1111/j.1532-5415.2012.03931.x. doi: 10.1111/j.1532-5415.2012.03931.x

Table 2.

Resident Characteristics and Risk Factors for Falls in Newly Admitted Nursing Home Residents Remaining in the Facility for at Least 30 Days

Resident Cohort Unadjusted Adjusted


Characteristic or Risk Factor Total (n = 230,730) Nonfallers (n = 182,980) Fallers (n = 47,750) OR (95% Confidence Interval)
Time interval to follow-up assessment, mean ± SD 62.9 ± 26.2 63.4 ± 25.6 61.0 ± 28.4
Age, mean ± SD 78.9 ± 12.2 78.5 ± 12.4 80.5 ± 10.9 1.01 (1.01–1.01)a 1.01 (1.01–1.01)a
Female, % 64.1 64.9 61.1 0.83 (0.81–0.85)a 0.79 (0.77–0.81)a
Race, %
    White (reference) 81.5 80.3 87.2
    Black 12.8 13.7 9.3 0.65 (0.63–0.67)a 0.81 (0.78–0.84)a
    Hispanic 4 4.3 3 0.72 (0.67–0.76)a 0.80 (0.75–0.85)a
    Other 1.7 1.7 1.5 0.86 (0.78–0.93)a 0.92 (0.84–1.01)
Medicare Part A, % 70.6 70.2 72.2 1.09 (1.06–1.12)a 1.00 (0.98–1.03)
Fall history, % 40.2 35.8 56.9 2.37 (2.32–2.42)a 2.31 (2.26–2.37)a
Comorbidity, %
    Diabetes mellitus 29.1 29.3 27.9 0.94 (0.92–0.97)a 1.09 (1.06–1.12)a
    Cerebrovascular accident 17.3 17 18.1 1.09 (1.06–1.12)a 1.15 (1.12–1.19)a
    Parkinson's disease 3.9 3.5 5.3 1.53 (1.46–1.61)a 1.24 (1.18–1.31)a
    Cardiac dysrhythmia 12.1 11.8 13.2 1.10 (1.06–1.13)a 1.03 (1.00–1.07)a
    Congestive heart failure 17.7 17.8 17.4 0.97 (0.94–0.99)a 1.03 (1.00–1.06)a
    Hypertension 53.5 53.6 53.8 0.99 (0.97–1.01) 0.96 (0.94–0.98)a
    Hypotension 1.1 1.1 1.3 1.16 (1.06–1.28)a 1.04 (0.95–1.15)
    Arthritis 19.7 19.7 19.9 0.98 (0.95–1.01) 0.95 (0.92–0.98)a
    Osteoporosis 11.2 11.2 11.5 1.00 (0.97–1.04) 0.92 (0.90–0.96)a
    Hip fracture 8.2 8 9.2 1.16 (1.12–1.20)a 0.88 (0.84–0.92)a
    Alzheimer's disease 11.9 11.5 13.8 1.21 (1.18–1.25)a 1.01 (0.97–1.04)
    Dementia 23.1 22.2 27.2 1.30 (1.27–1.33)a 1.05 (1.02–1.07)a
    Depression 26.8 26 29.8 1.20 (1.17–1.22)a 1.05 (1.02–1.08)a
    Emphysema or chronic obstructive pulmonary disease 15.5 15.7 15.1 0.95 (0.92–0.97)a 0.97 (0.94–1.00)a
    Diabetic retinopathy 0.4 0.4 0.4 0.87 (0.74–1.03) 1.00 (0.84–1.19)
    Glaucoma 4.5 4.4 4.5 1.01 (0.96–1.06) 0.95 (0.90–1.00)a
    Macular degeneration 2.7 2.6 3 1.11 (1.04–1.17)a 1.00 (0.94–1.07)
    Cataracts 2.6 2.6 2.7 1.00 (0.94–1.06) 0.97 (0.90–1.03)
    Urinary tract infection 18.6 18.5 18.9 1.02 (0.99–1.04) 0.97 (0.94–1.00)a
    Urinary incontinence 18.2 18.2 18.6 1.07 (1.04–1.10)a 0.97 (0.94–1.00)a
Symptoms in last 7 days, %
    Dizziness 1.6 1.4 2 1.22 (1.13–1.31)a 1.09 (1.01–1.17)a
    Syncope 0.6 0.4 0.9 1.40 (1.25–1.57)a 1.09 (0.96–1.22)
Medications
    Number of medications, mean ± SD 10.1 ± 4.6 10.1 ± 4.6 10.2 ± 4.5 1.00 (1.00–1.00)a 1.01 (1.00–1.01)a
    Antipsychotic medication, % 19.4 18.7 22.2 1.27 (1.24–1.30)a 1.07 (1.04–1.10)a
    Anti-anxiety medication, % 16.7 15.6 20.3 1.37 (1.34–1.41)a 1.26 (1.22–1.29)a
    Antidepressant, % 32.7 31.7 36.8 1.24 (1.22–1.27)a 1.18 (1.15–1.22)a
    Diuretic, % 31.3 31.5 30.3 0.93 (0.91–0.95)a 0.97 (0.94–0.99)a
    Hypnotic, % 8.5 8.4 8.9 1.07 (1.03–1.10)a 1.07 (1.03–1.11)a
Daily pain, % 20.1 20.4 18.9 0.88 (0.86–0.91)a 0.95 (0.92–0.97)a
Cognitive Performance Scale score, %
    0–2 (low) (reference) 54.6 56.8 46.4
    3–4 (moderate) 36.6 34.6 44.2 1.59 (1.56–1.63)a 1.38 (1.35–1.42)a
    5–6 (high) 8.8 8.6 9.4 1.37 (1.32–1.42)a 1.35 (1.29–1.41)a
Wandering in last 7 days, % 9 8.2 12.1 1.53 (1.48–1.58)a 1.28 (1.24–1.33)a
Body mass index, kg/m2, %
    <18.5 10.6 10.5 0.99 (0.96–1.03) 1.05 (1.01–1.08)a
    18.5–30.0 (reference) 70.6 69.7 74
    >30.0 18.8 19.8 15.1 0.71 (0.69–0.73)a 0.83 (0.81–0.86)a
ADL (range 0–28), mean ± SD 16.3 ± 6.9 16.3 ± 7.1 16.6 ± 6.2 1.01 (1.01–1.01)a 1.00 (1.00–1.00)
Impaired balance, % 91.9 91.3 94.2 1.52 (1.46–1.59)a 1.33 (1.27–1.40)a
Bedbound, % 3.5 3.9 2.1 0.53 (0.50–0.57)a 0.66 (0.62–0.71)a
Uses a cane, crutch, walker, % 33.3 32.2 37.8 1.27 (1.24–1.29)a 1.20 (1.17–1.23)a
Range of motion, %
    Limited in lower extremity 30.2 30.9 27.8 0.86 (0.84–0.88)a 0.88 (0.86–0.91)a
    Limited in feet 19.8 20.6 16.9 0.78 (0.76–0.80)a 0.93 (0.90–0.96)a
Restraints used daily in last 7 days, % 1.3 1.2 1.8 1.57 (1.44–1.70)a 1.04 (0.96–1.13)

Interpretation of continuous variables odds ratios (ORs): medication (adjusted model), for each additional medication per day there is a 1% increasein odds of a fall; activity of daily living (ADL) status in the unadjusted model can be interpreted as each additional unit increase in ADL score was associated with a 1% increase in odds of a fall.

SD=standard deviation.

a

P < .05.